Maximizing therapeutic envelope for prevention of cardiovascular disease: Role of polypill

Ginés Sanz, Valentin Fuster

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Cardiovascular-disease prevention is often inadequate due to several factors. Lack of professional adherence to guidelines, unaffordable medication, and lack of patients' adherence to treatment are the most important. It has been suggested that an affordable, fixed-dose combination drug containing evidence-based active compounds could improve cardiovascular prevention by improving patients' adherence to treatment. The available evidence suggests that the polypill strategy can achieve this objective and it will gain a place in the therapeutic armamentarium for the prevention of cardiovascular events in patients at high risk.

Original languageEnglish
Pages (from-to)683-688
Number of pages6
JournalMount Sinai Journal of Medicine
Volume79
Issue number6
DOIs
StatePublished - Nov 2012

Keywords

  • adherence to treatment
  • cardiovascular prevention
  • polypill
  • risk factors

Fingerprint

Dive into the research topics of 'Maximizing therapeutic envelope for prevention of cardiovascular disease: Role of polypill'. Together they form a unique fingerprint.

Cite this